Back to Results
First PageMeta Content
Financial economics / Equity securities / Stiefel Laboratories / Valuation / Corporate finance / Equity / Share repurchase / Stock / Public company / Finance / Stock market / Business


Complaint Against Stiefel Laboratories Inc. and Charles W. Stiefel
Add to Reading List

Document Date: 2011-12-12 11:47:25

Open Document

File Size: 819,78 KB

Share Result on Facebook

City

Coral Gables / Raleigh / /

Company

B. Stiefel Labs / The Blackstone Group LP / GlaxoSmithKline / Defendant Stiefel Laboratories Inc. / TA Associates Inc. / Sanofi / Glaxo / STIEFEL LABORATORIES INC. / Company for Billions / Blackstone Healthcare Partners LLC / BX Healthcare / Defendants Seek / A. Stiefel Labs / /

Country

United States / /

Currency

USD / /

Event

Security Buyback / M&A / Dividend Issuance / Bankruptcy / Funding / Reorganization / Employment Change / /

IndustryTerm

transportation / large pharmaceutical / dermatology products / private manufacturer / /

Organization

Plan Committee / UN Court / Securities and Exchange Commission / /

Person

CHARLES W. STIEFEL / Chainnan / /

Position

president / chairman and CEO / accountant / trustee / general counsel / director / and liquidation preferences / CEO and chairman / licensed attorney / senior advisor / managing director / financial adviser / Plan trustee / CEO and President / Chairman / CEO and President / licensed attorney in the state of New / member / /

ProvinceOrState

Delaware / Florida / North Carolina / New / /

SocialTag